Log In Get Started

News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Nebius shares pulled back from June highs, presenting a tactical buying opportunity.
  • The company shows an explosive revenue ramp supporting the valuation case.
  • Nebius owns its infrastructure, supporting operational control and scalable capacity.
  • Improving order books point to stronger near-term demand.
  • Recommended trade: buy at $168, stop at $140, target $240 over a 180-day campaign.
  • Plan explicitly sizes positions for elevated execution and macro risks.

Latest Articles

NANO Nuclear Energy Hires Marilyn Diaz, an Experienced Nuclear Fuel and Enrichment Regulatory Executive, as its Director of Fuel Facilities Operations
Sep 9, 2026
Ajmal Hussain
Press Releases

NANO Nuclear Energy Hires Marilyn Diaz, an Experienced Nuclear Fuel and Enrichment Regulatory Executive, as its Director of Fuel Facilities Operations

NANO Nuclear Energy Inc. (NASDAQ: NNE) announced the appointment of Marilyn Diaz, a seasoned nuclear regulatory executive with 17 years at the U.S. Nuclear Regulatory Commission, as Director of Fuel Facilities Operations. Diaz's expertise in nuclear fuel facility regulation and advanced reactor policy is expected to strengthen NANO Nuclear's vertic…

NNE
Bakkt Expands Global Commercial Team as Growth Accelerates; Raises 2026 Total Transacting Volume Target to $3 Billion
Sep 9, 2026
Priya Menon
Press Releases

Bakkt Expands Global Commercial Team as Growth Accelerates; Raises 2026 Total Transacting Volume Target to $3 Billion

Bakkt, Inc. announced the expansion of its global commercial team to accelerate the scaling of its digital asset infrastructure and payments platform. The company raised its 2026 Total Transacting Volume target from $2.5 billion to $3 billion, reflecting increased customer demand and a strong pipeline. Bakkt is also developing product suites target…

BKKT
MBX Biosciences to Participate in Upcoming Investor Conferences
Sep 9, 2026
Hana Yamamoto
Press Releases

MBX Biosciences to Participate in Upcoming Investor Conferences

MBX Biosciences, a clinical-stage biopharmaceutical company specializing in precision peptide therapies for endocrine and metabolic disorders, announced its CEO and CMO will present at the Morgan Stanley 24th Annual Global Healthcare Conference and the Stifel 2026 Virtual Cardiometabolic Forum. The company provides webcast access to these events th…

MBX
Mint Signed MOU with Edvance Innovation Limited to Expand into the Middle East and North Africa Education Robotics Market Through Distribution Partnership
Sep 9, 2026
Avery Klein
Press Releases

Mint Signed MOU with Edvance Innovation Limited to Expand into the Middle East and North Africa Education Robotics Market Through Distribution Partnership

Mint Incorporation Limited announced that its joint venture Rice Robotics AGI Holding Limited has signed a non-binding Memorandum of Understanding with Edvance Innovation Limited to establish a strategic distribution partnership focused on deploying educational robotics products and curricula across the Middle East and North Africa (MENA) region. T…

MIMI
AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX®
Sep 9, 2026
Sofia Navarro
Press Releases

AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX®

AEON Biopharma announced positive outcomes from a pilot forced degradation study comparing its biosimilar candidate ABP-450 to the reference product BOTOX®. The study demonstrated comparable potency loss patterns under thermal and oxidative stress, providing additional analytical evidence supporting structural and functional similarity. These findi…

AEON
EVgo and Regency Expand National Partnership to Bring Fast Charging to More Retail Centers Across the U.S.
Sep 9, 2026
Nina Shah
Press Releases

EVgo and Regency Expand National Partnership to Bring Fast Charging to More Retail Centers Across the U.S.

EVgo Inc., a leading public fast charging provider for electric vehicles, is expanding its partnership with Regency Centers Corporation to install over 400 new fast-charging stalls at Regency's shopping centers across multiple U.S. states. This expansion will increase Regency's EV charging footprint by more than 20%, providing convenient, high-spee…

EVGO
ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026
Sep 9, 2026
Jordan Park
Press Releases

ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026

ProQR Therapeutics has dosed the first healthy volunteer in its Phase 1 clinical trial for AX-0811, a next-generation RNA editing oligonucleotide targeting NTCP to treat cholestatic liver diseases such as biliary atresia. The trial will assess safety, tolerability, pharmacokinetics, and pharmacodynamics, with initial data expected in early 2027. Pr…

PRQR
Mount Logan Capital Inc. to Participate in the Lake Street Capital Markets 10th Annual Best Ideas Growth (BIG10) Conference
Sep 9, 2026
Marcus Reed
Press Releases

Mount Logan Capital Inc. to Participate in the Lake Street Capital Markets 10th Annual Best Ideas Growth (BIG10) Conference

Mount Logan Capital Inc., a US-based alternative asset management and insurance solutions firm, announced its participation in the Lake Street Capital Markets' 10th Annual Best Ideas Growth (BIG10) Conference. The company will host in-person one-on-one investor meetings to discuss its integrated investment and insurance strategies designed to produ…

MLCI
Barclays Raises S&P 500 Target, Citing Strong Q2 Earnings Led by Technology
Sep 9, 2026
Sofia Navarro
Stock Markets

Barclays Raises S&P 500 Target, Citing Strong Q2 Earnings Led by Technology

Barclays increased its year-end 2026 S&P 500 price target to 7,950 from 7,800 and kept the 2027 target at 8,800 after a strong second-quarter earnings cycle driven by technology companies. The bank raised fiscal 2026 and 2027 EPS estimates, highlighted broad earnings beats, and kept cautious valuation multiples despite improved fundamentals. Sector…

UBS Warns U.S. Stocks Are Most Exposed if Bond Yields Bite
Sep 9, 2026
Nina Shah
Stock Markets

UBS Warns U.S. Stocks Are Most Exposed if Bond Yields Bite

UBS HOLT analyst Michel Lerner cautions that U.S. equities may be the most vulnerable among developed markets if rising government bond yields begin to weigh on stocks. Lerner points to a mix of geopolitical and fiscal pressures that have pushed yields to levels not seen since before the global financial crisis, while equity valuations - particular…

Dow Weighs Selling Its 35% Stake in $20 Billion Sadara Chemicals Venture
Sep 9, 2026
Nina Shah
Stock Markets

Dow Weighs Selling Its 35% Stake in $20 Billion Sadara Chemicals Venture

Dow Inc. is considering options to divest its 35% stake in the $20 billion Sadara Chemical Co. joint venture with Saudi Aramco, according to Bloomberg News. The deliberations form part of Dow's portfolio reshaping in the face of an extended downturn in the chemicals sector. No final decision has been made, and discussions remain confidential.

Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2
Sep 9, 2026
Caleb Monroe
Press Releases

Serina Therapeutics Reports Cohort 1 Observations from SER-252 Registrational Study in Advanced Parkinson’s Disease and Advances to Cohort 2

Serina Therapeutics announced the Safety Monitoring Committee's recommendation to proceed to Cohort 2 in its Phase 1b registrational study of SER-252 for advanced Parkinson's disease after favorable blinded safety, tolerability, and pharmacokinetic data from Cohort 1. Early exploratory clinical observations indicated sustained motor function improv…

SER
SL Green Announces Sale of 110 Greene Street for $226 Million
Sep 9, 2026
Jordan Park
Press Releases

SL Green Announces Sale of 110 Greene Street for $226 Million

SL Green Realty Corp., Manhattan's largest office landlord, announced the sale of its 110 Greene Street office building in SoHo to Natora Group for $226 million. The transaction is expected to close in Q4 2026, generating approximately $216 million in net cash proceeds to repay unsecured corporate debt. The building was brought to full occupancy wi…

SLG
Fluence: Buy the Factory Catch-Up Trade as Orders Outpace Production
Sep 9, 2026
Ajmal Hussain
Trade Ideas

Fluence: Buy the Factory Catch-Up Trade as Orders Outpace Production

Fluence’s backlog and strategic partnership with Nvidia point to solid demand from AI data centers and utilities. The stock trades at $11.04 with a market cap around $2.04B, negative free cash flow, and meaningful short interest. This idea is a directional long that exploits an expected re-rating if manufacturing throughput and margins begin to nor…

FLNC
Credo: Buy the AI Connectivity Pullback - Tactical Long (Upgrade)
Sep 9, 2026
Hana Yamamoto
Trade Ideas

Credo: Buy the AI Connectivity Pullback - Tactical Long (Upgrade)

Credo has the connectivity products that matter to hyperscale AI clusters. Recent sell-offs reflect margin noise and concentration fears, but the company's top-line is accelerating sharply: Q1 revenue $479M (+114.7% YoY) and FY2026 revenue topped $1.3B. At $167.86 the stock underprices a multi-year shift to higher-speed optics and near-package conn…

CRDO